Found: 41
Select item for more details and to access through your institution.
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize.
- Published in:
- Nature Communications, 2016, v. 7, n. 10, p. 13019, doi. 10.1038/ncomms13019
- By:
- Publication type:
- Article
Chemoradiation for patients with advanced oral cavity cancer.
- Published in:
- Laryngoscope, 2010, v. 120, n. 1, p. 93, doi. 10.1002/lary.20716
- By:
- Publication type:
- Article
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Single Sample Expression-Anchored Mechanisms Predict Survival in Head and Neck Cancer.
- Published in:
- PLoS Computational Biology, 2012, v. 8, n. 1, p. 1, doi. 10.1371/journal.pcbi.1002350
- By:
- Publication type:
- Article
Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22619-w
- By:
- Publication type:
- Article
DNA Repair Biomarkers XPF and Phospho-MAPKAP Kinase 2 Correlate with Clinical Outcome in Advanced Head and Neck Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0102112
- By:
- Publication type:
- Article
p62/SQSTM1 Accumulation in Squamous Cell Carcinoma of Head and Neck Predicts Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090171
- By:
- Publication type:
- Article
Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial
- Published in:
- Trials, 2014, v. 15, n. 1, p. 2, doi. 10.1186/1745-6215-15-469
- By:
- Publication type:
- Article
Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31941-w
- By:
- Publication type:
- Article
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31601-z
- By:
- Publication type:
- Article
Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 8, p. 1303, doi. 10.1002/cncr.29207
- By:
- Publication type:
- Article
Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 17, p. 2694, doi. 10.1002/cncr.28766
- By:
- Publication type:
- Article
Modifiable risk behaviors in patients with head and neck cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 13, p. 2419, doi. 10.1002/cncr.27993
- By:
- Publication type:
- Article
Stereotactic body radiotherapy for multisite extracranial oligometastases.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 11, p. 2962, doi. 10.1002/cncr.26611
- By:
- Publication type:
- Article
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 20, p. 4671, doi. 10.1002/cncr.26084
- By:
- Publication type:
- Article
American Cancer Society Head and Neck Cancer Survivorship Care Guideline.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report.
- Published in:
- Journal of Otolaryngology -- Head & Neck Surgery, 2022, v. 51, n. 1, p. 1, doi. 10.1186/s40463-022-00556-y
- By:
- Publication type:
- Article
Chemoradiation for patients with large-volume laryngeal cancers.
- Published in:
- Head & Neck, 2012, v. 34, n. 8, p. 1162, doi. 10.1002/hed.21888
- By:
- Publication type:
- Article
Novel molecular targeted therapies for refractory thyroid cancer.
- Published in:
- Head & Neck, 2012, v. 34, n. 5, p. 736, doi. 10.1002/hed.21755
- By:
- Publication type:
- Article
Airway management before chemoradiation for advanced head and neck cancer.
- Published in:
- Head & Neck, 2012, v. 34, n. 2, p. 254, doi. 10.1002/hed.21729
- By:
- Publication type:
- Article
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.
- Published in:
- Head & Neck, 2009, v. 31, n. 8, p. 1006, doi. 10.1002/hed.21052
- By:
- Publication type:
- Article
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
- Published in:
- Head & Neck, 2009, v. 31, n. 8, p. 1013, doi. 10.1002/hed.21062
- By:
- Publication type:
- Article
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-473
- By:
- Publication type:
- Article
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-473
- By:
- Publication type:
- Article
Current perspectives on recurrent HPV-mediated oropharyngeal cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.966899
- By:
- Publication type:
- Article
Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.738626
- By:
- Publication type:
- Article
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-13471-0
- By:
- Publication type:
- Article
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 736, p. 1, doi. 10.1126/scitranslmed.abj9905
- By:
- Publication type:
- Article
Pan-Cancer Analysis of Patient Tumor Single-Cell Transcriptomes Identifies Promising Selective and Safe Chimeric Antigen Receptor Targets in Head and Neck Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4885, doi. 10.3390/cancers15194885
- By:
- Publication type:
- Article
Treatment of metastatic urothelial cancer in the post-MVAC era.
- Published in:
- World Journal of Urology, 2001, v. 19, n. 2, p. 126, doi. 10.1007/s003450000193
- By:
- Publication type:
- Article
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Advances in the Management of Metastatic Head and Neck Squamous Cell Cancer: A Closer Look at the Integration of Immunotherapy.
- Published in:
- Journal of Managed Care Medicine, 2018, v. 21, n. 3, p. 70
- By:
- Publication type:
- Article
Evolving Considerations in the Management of Metastatic Head and Neck Squamous Cell Carcinoma: Expert Strategies on Immune Checkpoint Inhibitors.
- Published in:
- Journal of Managed Care Medicine, 2022, v. 25, n. 4, p. 29
- By:
- Publication type:
- Article
A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0152995
- By:
- Publication type:
- Article
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo.
- Published in:
- 2015
- By:
- Publication type:
- journal article